
Loading, please wait...

Loading, please wait...

Chlorohydrins represent vital intermediates in organic synthesis. They facilitate the production of bioactive molecules and critical pharmaceutical compounds used worldwide. Traditionally, creating these substances requires hazardous conditions and toxic reagents. However, researchers have now developed a significant breakthrough in sustainable chlorohydrin synthesis. By utilizing a specialized RuSnNbO polymetallic oxide catalyst, the team successfully converted commodity alkenes into chlorohydrins using seawater as a chloride source.
This electrocatalytic strategy operates efficiently in simple sodium chloride solutions. Notably, cyclohexene transforms into 2-chlorocyclohexanol with a Faradaic efficiency of 96.1%. Furthermore, the selectivity reaches nearly 99% at specific voltages versus a reversible hydrogen electrode. This approach also applies to other common alkenes like styrene and cyclopentene. Therefore, manufacturers can produce various drug precursors without compromising quality or chemical yield.
The environmental impact of this method is significant. Most conventional manufacturing processes rely on stoichiometric oxidants or hazardous chlorine gas. In contrast, this new technique generates active surface chlorine intermediates on-site from seawater. This shift eliminates the need for transporting and handling dangerous chemicals. Moreover, the process successfully scales to gram-levels in acidic seawater environments. Consequently, this innovation provides a scalable and sustainable alternative for the global pharmaceutical industry.
Chlorohydrins serve as essential building blocks for synthesizing bioactive molecules. They are widely used in drug discovery and the production of green catalysts for various therapeutic developments.
Seawater provides a natural and abundant source of chloride ions. Utilizing seawater eliminates the need for expensive purified reagents and promotes sustainable, eco-friendly manufacturing practices.
The catalyst allows the reaction to occur under milder conditions compared to traditional chemical methods. By generating reactive chlorine species directly on the electrode surface, it avoids the industrial handling of toxic chlorine gas.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or clinical guidelines. Refer to the latest local and national guidelines for clinical practice.
References
Huang Y et al. Electrosynthesis of Chlorohydrins From Alkenes in Seawater Enabled by On-Site Generated Active Surface Chlorine Intermediate. Angew Chem Int Ed Engl. 2026 Feb 25. doi: 10.1002/anie.4054670. PMID: 41738336.
Sheldon RA. The E Factor 25 years on: the evolution of green chemistry and sustainability. Green Chem. 2017;19(1):18-43.
Atia JH et al. Electrocatalytic transformations of biomass-derived compounds. Chem Soc Rev. 2021;50(11):6399-6460.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers have developed a sustainable method to produce chlorohydrins from seawater, improving safety and efficiency for pharmaceutical manufacturing....
7 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today